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Available online 24 February 2011Amyotrophic lateral sclerosis (ALS) is a progressive degenerative disorder affecting
motoneurons and the SOD1G93A transgenic mice are widely employed to study disease
physiopathology and therapeutic strategies. Despite the cellular and biochemical
evidences of an early motor system dysfunction, the conventional behavioral tests do
not detect early motor impairments in SOD1 mouse model. We evaluated early changes in
motor behavior of ALS mice by doing the analyses of tail elevation, footprint, automatic
recording of motor activities by means of an infrared motion sensor activity system and
electrophysiological measurements in male and female wild-type (WT) and SOD1G93A
mice from postnatal day (P) 20 up to endpoint. The classical evaluations of mortality,
weight loss, tremor, rotometer, hanging wire and inclined plane were also employed.
There was a late onset (after P90) of the impairments of classical parameters and the
outcome varied between genders of ALS mice, being tremor, cumulative survival, weight
loss and neurological score about 10 days earlier in male than female ALS mice and also
about 20 days earlier in ALS males regarding rotarod and hanging wire performances.
While diminution of hindpaw base was 10 days earlier in ALS males (P110) compared to
females, the steep length decreased 40 days earlier in ALS females (P60) than ALS males.
The automatic analysis of motor impairments showed substantial late changes (after P90)
of motility and locomotion in the ALS females, but not in the ALS males. It was surprising
that the scores of tail elevation were already decreased in ALS males and females by P40,
reaching the minimal values at the endpoint. The electrophysiological analyses showed
early changes of measures in the ALS mouse sciatic nerve, i.e., decreased values of
amplitude (P40) and nerve conduction velocity (P20), and also an increased latency (P20)
reaching maximal level of impairments at the late disease phase. The early changes were
not accompanied by reductions of neuronal protein markers of neurofilament 200 and
ChAT in the ventral part of the lumbar spinal cord of P20 and P60 ALS mice by means of
Western blot technique, despite remarkable decreases of those protein levels in P120 ALSKeywords:
Amyotrophic lateral sclerosis
Mutant SOD1G93A
Early motor impairments
Footprint
Tail elevation gender
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91B R A I N R E S E A R C H 1 3 9 4 ( 2 0 1 1 ) 9 0 – 1 0 4mice. In conclusion, early changes of motor behavior and electrophysiological parameters
in ALS mouse model must be taken into attention in the analyses of disease mechanisms
and therapeutic effects.
© 2011 Published by Elsevier B.V. Open access under the Elsevier OA license.Fig. 1 – Tremor onset and survival time. Kaplan–Meier curves
comparing tremor onset and survival time between groups of
male and female SOD1G93A mice. Clinical symptom onset
(tremor inat leastonehind limbupontail suspension)occurred
significantly (p<0.01) sooner inmale (P100) (n=28) compared to
female (P110) (n=25) SOD1G93A mice. Survival time (animals
unable to right themselves within 30 seconds) showed a
gender difference (p<0.05) among male (P125) (n=25) and
female (P135) (n=28) SOD1G93A mice. The number of wild-type
mice was as follows: females n=10 and males n=11.1. Introduction
Amyotrophic lateral sclerosis (ALS) is an adult-onset neuro-
degenerative disorder involving motoneuron loss in the brain,
brainstem, and spinal cord leading to progressive paralysis
and death after 3–5 years from respiratory failure (Bruijn et al.,
2004; Ince et al., 1998).
Themajority of ALS cases are apparently sporadic, with 90–
95% of patients presenting disease symptoms without a
familial history of the pathology, and the remaining 5–10%
patients are included as a familial ALS group. Both types of
ALS are, however, indistinguishable in the clinical outcome
(Bruijn et al., 2004). About 25% of familial cases are caused by
dominant mutations in the Cu/Zn super oxide dismutase
(SOD1) gene (Andersen, 2004).
Several transgenic rodent models of ALS have been devel-
oped for assessing novel therapeutic interventions, being the
SOD1G93A mouse model the most widely studied. This model
was generated by over expression of mutant allele of human
SOD1 gene carrying the glycine to alanine substitution at
position 93 (Gly93 → Ala), resulting in a toxic gain of mutant
molecule (Gurney et al., 1994; Yim et al., 1996). The clinical
phenotype of that animal model is characterized by an adult-
onset of motor signs in the hindlimbs around 90 days of age,
which progress rapidly to the end stage by 130–150 days (Dal
Canto and Gurney, 1997). At the cell level, several structural
changes in neurons and glial cells are known to precede
neurodegeneration that takes place in the course of classical
symptoms (Durand et al., 2006). In fact, for instance, the
appearance of small vacuoles and early axonal retraction in
the axons of motoneurons of 37- to 47-day-old non symptom-
atic SOD1G93Amicemight represent important pathophysiolog-
ical issues influencing the disease onset and/or progression
(Bruijn et al., 2004; Chiu et al., 1995; Fischer et al., 2004).
Recent papers have pointed out the appearance of early
motor impairments that anticipate the classical signs of disease
(Browne et al., 2006; Niessen et al., 2007; Ringer et al., 2009). Such
early behavioral changes must be evaluated in more details
because they could beof valuable contribution in the analyses of
the effects of preclinical therapeutical approaches and also to
interpret better the significanceof preclinical cellular/molecular
changes in the physiopathology of the disease.
Conventional tests used for assessingmotor function in ALS
rodentmodels, like rotarod, hangingwire and inclinedplane are
not able to detect deficits that occur early in the disease process
(Knippenberg et al., 2010). Tail elevation is a parameter used in
the generalized neurological screens to assess phenotypes in
large-scale multicenter random programs and it has not been
used in the clinical evaluation of ALSmodel (Rogers et al., 1997).
Therefore, the purpose of this study was to investigate the
progression of motor impairments in freely behaving presymp-
tomatic SOD1G93A mice beginning at postnatal day (P) 20, by
means of the evaluation of tail elevation, footprint analyses andautomatic recordings of motor activities by an infrared motion
sensor activity system. The analyses were continued in the
symptomatic periods in parallel to conventional evaluation of
body weight and neurological score as well as tests like rotarod,
hanging wire and inclined plane. We have also performed
electrophysiological registers of the compound motor action
potential (CMAP) parameters amplitude, latency and nerve
conduction velocity. To evaluate whether early behavioral
changes are associated to motoneuron degeneration, we
conducted quantitative Western blot analysis of neuronal
markers in the spinal cord of presymptomatic (P20 and P60)
and symptomatic (P120) ALS mice.2. Results
2.1. Survival time, body weight and neurological score
There was a gender difference (p<0.05) in the survival time
between groups ofmale (P125) and female (P135) SOD1G93Amice
(Fig. 1). Two-way ANOVA showed time-dependent differences
of bodyweightbetweengroupsof transgenic andwild-type (WT)
males as well as transgenic and WT females and also among
genders of transgenic animals (Fig. 2A, B; Table 1). Bonferroni
comparisons of WT and SOD1 demonstrated a weight loss
(p<0.001) occurring after P90 in males and P110 in females
(Fig. 2A, B). By weekly monitoring using the neurological score,
tremors were recorded and disease progression was evaluated.
TheWTanimals never showed signs ofmotor dysfunction. The
Fig. 2 – Body weight and neurological score. Changes over time in body weight (gram, A, B) and neurological score (C, D) of male
(A, C) and female (B, D)wild-type (WT) and transgenic SOD1G93Amiceweremonitoredweekly fromP20 to P130. See text for details
regarding neurological score. ***p<0.001, two-way ANOVA, followed by Bonferroni post-test. Means±SEM. The numbers of
animals were as follows:WT females n=10, 27 andmales n=9, 27; transgenic females n=9, 27 andmales n=9, 27 for bodyweight
and neurological score, respectively. The results of two-way repeated measure analyses of variance are shown in Table 1.
92 B R A I N R E S E A R C H 1 3 9 4 ( 2 0 1 1 ) 9 0 – 1 0 4Kaplan–Meier (log-rank test) analysis showed the tremor onset
occurring significantly sooner (p<0.01) inmale (P100) compared
to female (P110) SOD1G93A mice (Fig. 1). In relation to the motor
impairments evaluated by neurological score, the two-way
ANOVA showed time-dependent differences between groups of
transgenic andWTmalesaswell as femalesanda trend (p=0.07)
for difference between genders of transgenic animals (Fig. 2C, D;
Table 1). Bonferroni comparisons of WT and SOD1 revealed the
first decreases of the neurological score occurring at 90 days of
age (p<0.001) for ALS males and at 100 days of age (p<0.001) for
ALS females, that were worsened at the subsequent periods
(Fig. 2C, D).
2.2. Behavioral analysis
2.2.1. Rotarod, hanging wire and inclined plane
The results of the rotarod, hanging wire and inclined plane tests
are shown in Fig. 3A–F. The two-way ANOVA showed time-
dependent differences between groups of transgenic and WT
males as well as females for the three tests, and also between
genders of transgenic animals (Table 1). Bonferroni comparisons
of WT and SOD1 demonstrated a decreased performance oftransgenic males 10 to 20 days earlier compared to transgenic
females for hanging wire and rotarod, respectively. Moreover, in
inclined plane test, significant differences between groups ofWT
andSOD1mice appeared lately in relation to the other tests, with
aworse performance of transgenic females at P120 (p<0.001) and
for transgenic males at P130 (p<0.001) when comparing with
their respective WT. Other differences regarding the isolated
effects of gender or age in the strands are presented in Table 1.
2.2.2. Tail elevation
An impairment in tail elevation was the first clinical sign
found in the SOD1G93A male and female mice that appeared in
both genders already by P40 and remained different of their
respective controls throughout period of analysis (Fig. 4A, B).
Despite the tail of transgenic males acquired a horizontal
position (score 1) earlier than transgenic females (Fig. 4A, B),
the two-way ANOVA showed differences in the interaction of
genotype/age between transgenic and WT for both genders,
but not between genders of transgenic mice (Table 1). The
scores ofWT animals demonstrated a constant andmaximum
elevation of the tail over the entire observation period (score
zero in the vertical axis). Other differences regarding the
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93B R A I N R E S E A R C H 1 3 9 4 ( 2 0 1 1 ) 9 0 – 1 0 4isolated effects of gender or age in the strands are presented in
Table 1.
2.2.3. Footprint analysis
The results of the footprint analyses of step length and hind
paw base are shown in Figs. 5A–D; 6A, B. The two-way ANOVA
showed time-dependent differences between groups of trans-
genic and WT males as well as females for step length and
base width measures (Table 1). The evaluation of the
spreading toes showed a time-dependent decrease of the
values (data not shown) between groups of transgenic andWT
males and a trend (p=0.07) for reduction between transgenic
and WT females (Table 1). Time-dependent differences were
found between genders of transgenic mice for step length and
base width parameters (Table 1). Bonferroni comparisons of
WT and SOD1 demonstrated decreases in the step length
measures of transgenic females 40 days earlier than trans-
genic males and in the base width measures of transgenic
males 10 days earlier than transgenic females (Fig. 5A–D, also
illustrated in Fig. 6). Other differences regarding the isolated
effects of gender or age in the strands are demonstrated in
Table 1.
2.3. Automatic evaluation
The results of automatic evaluation by infrared motion sensor
activity system are shown in the Fig. 7A–F. Despite some
differences in the three analyzed parameters (without move-
ment events, small movement events, large movement events)
regardingageor genotypebetweengroupsofWTandtransgenic
mice of both genders, the two-way ANOVA demonstrated time-
dependent interactions only for large movement events be-
tween groups of WT and transgenic females and also between
genders of transgenicmice (Table 1). Bonferroni comparisons of
WT and transgenic females demonstrated increases of without
movement events and large movement events developed by
SOD1G93A females compared to WT females in the III and IV
periods of analysis (Fig. 7A–F).
It should be noticed that two-way ANOVA also pointed the
differences in the interaction gender/age between male and
female WT in the body weight, rotarod and large movement
event measurements (Table 1).
2.4. Electrophysiological measurements
In order to determine whether there were differences in
latency, velocity and amplitude in the conduction of the nerve
input in the sciatic nerve of SOD1G93A comparedwithWTmale
littermates, we recorded the parameters between the time of
the stimulus onset in the nerve and the initial positive
potential recorded in gastrocnemius muscle. Since the eva-
luations were done in different groups of WT and transgenic
mice with specific ages, the results were treated with Mann–
Whitney U-test and not evaluated with two-way ANOVA
(Fig. 8A–C). CMAP amplitude was decreased (p<0.05) at P40 in
SOD1mice compared to controls and no differences have been
detected at P60 and P80 (Fig. 8A). Changes in the amplitude
was found again in the sciatic nerve of ALS mice at the end
stage (P120) of the diseasewhen the recording decreased again
in SOD1G93A animals (p<0.01) compared to WT. We observed
Fig. 3 – Rotarod, hangingwire and inclined plane. Changes over time in the rotarod (A, B), hangingwire (C, D) and inclined plane
(E, F) performances (seconds) of male (A, C, E) and female (B, D, E) wild-type (WT) and transgenic SOD1G93A mice were
monitored weekly from P20 to P130. *p<0.05, **p<0.01, ***p<0.001, two-way ANOVA, followed by Bonferroni post-test.
Means±S.E.M. The numbers of animals were: WT females n=13, 11 and males n=15, 10; transgenic females n=15, 10
and males n=15, 10 for rotarod and hanging wire, respectively. The results of two-way repeated measure analyses of
variance are shown in Table 1.
94 B R A I N R E S E A R C H 1 3 9 4 ( 2 0 1 1 ) 9 0 – 1 0 4increases in the latency in the conduction of the nerve input in
the sciatic nerve of SOD1G93A mice already at P20 (p<0.05) with
a maximum value by P120 (Fig. 8B) when compared with WT
animals. The nerve conduction velocity was decreased in
SOD1mice from P20 (p<0.05) up to the final point of disease at
P120 (Fig. 8C).2.5. Western blot analysis
To determine whether these early motor phenotypes are
associated with spinal cord motoneurons degeneration, we
conducted Western blot analyses using antibodies to the
cytoskeletal neuronal marker neurofilament 200 (NF-200) and
Fig. 4 – Tail elevation. Changes over time in tail elevation accessed by tail score measurements (see text for details) of male
(A) and female (B) wild-type (WT) and transgenic SOD1G93A mice were monitored weekly from P20 to P130. *p<0.05, **p<0.01,
***p<0.001, two-way ANOVA, followed by Bonferroni post-test. Means±SEM. n=9, in all evaluated groups. The results of
two-way repeated measure analyses of variance are shown in Table 1.
95B R A I N R E S E A R C H 1 3 9 4 ( 2 0 1 1 ) 9 0 – 1 0 4to the motoneuron marker choline acetyltransferase (ChAT) in
the presymptomatic (P20 and P60) and symptomatic (P120)
SOD1G93A and WT female mice of respective age. Although weFig. 5 – Footprint analyses. Changes over time in step length (A, B
male (A, C) and female (B, D) wild-type (WT) and transgenic SOD1
**p<0.01, ***p<0.001, two-way ANOVA, followed by Bonferroni p
results of two-way repeated measure analyses of variance are shfound early motor impairments at presymptomatic ages, no
evidence for neuronal loss was found in ventral portion of the
lumbar spinal cord of SOD1G93A mice compared with WT) and hind paw base (C, D) (measurements in centimeters) of
G93A mice were monitored weekly from P20 to P130. *p<0.05,
ost-test. Means±SEM. n=11, in all evaluated groups. The
own in Table 1.
Fig. 6 – Walking pattern. (A) Footprints of a wild-type mouse
at the 120 days of age. Three-step parameters were
measured by footprint analyses: stride length, hind base
width and spreading of toes. (B) Footprints of a SOD1G93A
mouse at the same age (symptomatic stage) of theWTmouse
presented in A.
96 B R A I N R E S E A R C H 1 3 9 4 ( 2 0 1 1 ) 9 0 – 1 0 4animals as seen by the unaltered levels of neurofilament 200
(Fig. 9) andChAT (not shown). At the symptomatic age however,
the levels of neurofilament and ChAT decreased substantively
(Fig. 9A, B). The levels of neurofilament 200 increased in
postnatal development of normal mice, which was already
described (Riederer et al., 1996; Schlaepfer and Bruce, 1990), thus
highlighting its diminution at the late stage of the disease.3. Discussion
The identification of early motor deficits in transgenic animal
models of ALS is crucial for the development of therapeutical
strategies aimed at preventing motoneuron cell death. Howev-
er, conventional tests used for assessingmotor function in these
animals, which are mainly relied on forced exercise tasks, are
not sensitive enough to detect early behavior abnormalities
(Hayworth and Gonzalez-Lima, 2009). Therefore, in addition to
conventional forced exercise tests (rotarod, hanging wire and
inclinedplane) andalso the classical assessmentofneurological
scoreandbodyweight,we investigated theprogressionofmotorperformance deficits in freely behaving presymptomatic
SOD1G93A mice beginning at P20, using the evaluation of tail
elevation, footprint analyses and automatic (observer-indepen-
dent) motor activities by an infrared motion sensor activity
system. We also performed electrophysiological evaluations in
order tomeasure the CMAP parameters (amplitude, latency and
conduction velocity) in the mouse sciatic nerve.
Previously, the earliest reported behavioral symptom in the
SOD1G93A mice was a fine tremor of the hindlimbs observed
around 100 days of agewhen animals were suspended by their
tails (Barneoud et al., 1997; Chiu et al., 1995). We found a
tremor onset in freemoving transgenicmales by P100 thatwas
delayed in the ALS females (P110), which is in agreement with
a previous paper (Veldink et al., 2003), despite some studies
have reported no sex differences in tremor onset in SOD1G93A
mice (Heiman-Patterson et al., 2005; Knippenberg et al., 2010).
Such discrepancies may be due to the subjective nature of the
examination of initial tremor.
There has been a varied range of body weight impairments
reported for SOD1G93A mice (Chiu et al., 1995; Fischer et al.,
2004; Knippenberg et al., 2010). Our results are in agreement to
those of Weydt et al. (2003) showing an overall difference of
the body weight among SOD1G93A andWTmice with the onset
of weight loss for males (P90) and for females (P110) near the
age of tremor onset.
Several studies have described longer survival of females
thanmales in SOD1G93Amice (Choi et al., 2008; Kirkinezos et al.,
2003) while others have reported no significant gender differ-
ences (Hayworth and Gonzalez-Lima, 2009; Knippenberg et al.,
2010). Our results showed a significant gender difference in the
average survival time for males (P125) and for females (P135).
The rotarod was specifically designed for making mea-
surements of neurological deficits in rodents (Dunham and
Miya, 1957), and it is one of the most commonly used test of
motor impairment inmice. Our results showed an earlier less
balance of SOD1G93A male (P90) than female (110) mice on
rotarod apparatus than respective controls. Those findings
are in agreement to Smittkamp et al. (2008) (females at P113)
and to Kirkinezos et al. (2003) (males at P100) and in
disagreement to others that showed the onset of impaired
performance of ALS females in the rotarod by P75 (Hayworth
and Gonzalez-Lima, 2009; Kirkinezos et al., 2003). Differences
in the protocols, diameter of the rotating cylinders and
genetic background of mutant SOD1G93A mice may explain
the different published results of the rotarod test (Brooks and
Dunnett, 2009).
In our study, the hanging wire sensitivity to detect the
onset of ALS behavioral impairments seemed to be similar to
rotarod. Like rotarod results, the impaired hanging wire
performance was earlier in males (P100) than females (P110),
thus near the classical symptom onset (fine tremor of the
hindlimbs). Our results suggest that although rotarod and
hanging wire may be good tools for evaluating balance,
coordination and strength in late stage of disease progression,
these tests are not sensitive measures to detect early motor
changes of the disease in ALS mice as discussed below.
Barneoud et al. (1997) have reported an early deficit in the
inclined plane by SOD1G93Amice (P60) by employing a different
protocol of analysis.We showed significant differences among
WT and SOD1G93Amice in the inclined planemeasureswith an
Fig. 7 – Motor activity by automatic evaluation. Changes over time in spontaneous activity corresponding to number
without movement events (A, D), small movement events (0.01-second duration, motility) (B, E) and large movement events
(1.0-second duration, locomotion) (C, F) of male (A, B, C) and female (D, E, F) wild-type (WT) and transgenic SOD1G93A mice
were measured by means of an Infrared Motion Sensor Activity Monitor weekly from P40 to P120. The data were pooled in
periods of analysis: period I (P40–60), II (P70–80), III (P90–100) and IV (P110–120) *p<0.05, **p<0.01, two-way ANOVA, followed
by Bonferroni post-test. Means±SEM. n=11, in all evaluated groups. The results of two-way repeated measures analyses of
variance are shown in Table 1.
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thus later than the first behavioral differences pointed by
others tests and therefore less sensitive to detect early motor
deficits in ALS mouse model.
We also found a very early (P40) and progressive impair-
ment in tail elevation in SOD1G93A male and female micecompared with WT. To our knowledge, it is the first time such
an early impairment in tail elevation of ALS rodents has been
reported, despite a recent publication (Suzuki et al., 2010) that
showed an increased tone in the tail musculature, resulting in
a contractured segmentally spastic tail posture by P130 in ALS
mice of both genders. Tail elevation is a parameter used in the
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Royal London Hospital phenotype assessment (SHIRPA) screen.
SHIRPA battery was developed as a generalized neurological
screen to assess phenotypes in a large-scale multicenter
random mutagenesis program (Rogers et al., 1997). Using the
SHIRPA tail score modified by our group, the animals were
classified in 4 different grades to describe tail elevation. WTFig. 8 – Electrophysiological measurements. Changes over
time in evoked Compound Motor Action Potential (CMAP) in
the gastrocnemius muscle after stimulation of the sciatic
nerve in male wild-type (WT) and transgenic SOD1G93A mice
were monitored at P20, P40, P60, P80, P100 and P120. The
data of CMAP amplitude (A) are expressed in milivolts (the
data of P100 animals were missed), the data of latency (B) are
expressed in milliseconds and the data of nerve conduction
velocity (C) are expressed in meters per second (m/s).
*p<0.05, **p<0.01, Mann–Whitney U-test. Means±SEM. n=5,
in all evaluated groups.animals maintained a constant and maximum vertical eleva-
tion of the tail over the whole observation period. P30–40 ALS
males showed an earlier and faster decline in the tail score
compared with ALS females. After that period, the aspect of the
progressive impairment in the shapepositionwas similar in the
transgenes of both genders. Thismayexplain the results of two-
way ANOVA on significances between transgenic male and
female groups regarding gender and animal age without
difference in the interaction gender versus age. Moreover, the
first deficit in tail elevation was horizontal and dragging
positioning suggesting a proximal muscle weakness. Later, as
the classical signals of disease progress, spasticity and hyperre-
flexia took place.
We have also found marked differences in gait pattern
between WT and SOD1G93A groups of mice. Our results in
footprint analyses are in partial agreement to previous
publications that reported a shortened gait by about P125 for
ALS males and females (Chiu et al., 1995; Knippenberg et al.,
2010), a little later than that found in our study for ALS male
mice (P100) and substantially different (later) from our
transgenic females in which that parameter corresponded to
an important early (P60) signal of the disease. Such differences
found in the published reports may be due to the number of
evaluated animals and individual variability. Other point to
take into attention is the detail of the genotype of transgenic
strands bearing the number of copies of mutant human SOD1
gene that could interfere in the phenotype of the colony, or
also the genetic backgrounds (Heiman-Patterson et al., 2005),
that are not commonly shown in the descriptions. Anyhow, it
should be noticed that the timing of early appearance of step
length changes in ALS females in our study correspondedwith
the timing of the early changes of the motor unit or
neuromuscular junction reported previously (Fischer et al.,
2004; Frey et al., 2000; Kennel et al., 1996). Furthermore, the
early changes in the hind paw step angle and hind paw stance
width in SOD1G93A males and females at P45–60 reported
previously (Guillot et al., 2008) opened up the possibility for
additional findings in more accurate ongoing future analyses.
We also observed later changes in hind paw base measures in
transgenic males and also females, an occurrence that has not
been described for ALS rodent models. It is possible that the
later deterioration of the neurological condition has allowed
the ALS females to adapt stepping earlier toward a diminution
of the step lengthwhich has prompted thema later basewidth
decrement, an adaptive behavior not evidenced in the early-
compromised ALS males.
Regarding the spontaneous motor behavior, we observed
the appearance of significant increases in number of events
Fig. 9 – Western blot analysis. The relative optical density of
cytoskeletal neuronal marker neurofilament 200 (200 kDa) by
means of Western blot analysis in the ventral region of the
lumbar spinal cord of wild-type (WT) and transgenic
SOD1G93A female mice at different postnatal ages (P20, P60,
P120) is shown in A. The representative bands of the
neurofilament 200 of animals as well as of the choline
acetyltransferase (ChAT, 68 kDa) of P120 WT and SOD1 mice
are illustrated in B.β-Tubulin III (55 kDa) was used as sample
loading control. One-way analysis of variance (ANOVA) was
applied to compare the groups. The numbers represent the
mean±SEM. n=5 (WT) and 6 (transgenic).
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movement in females SOD1G93A in the third period of analysis
(P90–100). Interestingly, no changes in the spontaneous
movement were detected in the ALS males compared to
control. Infrared motion sensor activity system has been used
to show motor impairment in the open field of rodents with
spinal cord injury (Andrade et al., 2010; Guzen et al., 2009).
Overall, the first appearances of impairments in neurological
score, fine tremors in the hindlimbs, the rotarod, hanging wire
and inclined plane performance were earlier in transgenic
males than transgenic females, different from the onset of
step length impairment in the footprint that was earlier in
transgenic females compared to transgenic males. It is
possible that the later detrimental evolution of several major
parameters in transgenic females with earlier decreases of
step length has allowed those females to adapt themselves in
the open fields, in line regarding the gender difference in the
step length, by increasing the number of largemovements and
consequently the number of events without movements. The
transgenic males did not have the opportunity to adapt the
spontaneous locomotion because their more precocious
deterioration of general condition. It is also possible that the
infraredmotion sensor activity systemwas not able to register
the fine tremor described herein because no statistical
differences were found regarding the number of small move-
ments between strands of both genders.
Deterioration of the nerve conduction could be assessed by
electrophysiologicalmeasurements. However, few studies havedetailed functional changes in nerve conduction in the ALS
rodent models despite the importance of the evaluation at
clinical practice. Our results are in line and extend a prior
description that has shown early changes in the electrical
properties of sciatic nerve of SOD1G93A mice. Decrease in the
amplitude by P63 (Azzouz et al., 1997) was registered in the
sciatic nerve of SOD1G93A. We have contributed to this analysis
by showing early changes in electrophysiological parameters by
P20–40, which might be related to a very precocious functional
impairment of motoneurons (Shefner et al., 2002) and/or
decreases of motor units (Fischer et al., 2004; Frey et al., 2000;
Kennel et al., 1996) in the SOD1G93Amice at P47–60. Furthermore,
the massive changes in the electrophysiological parameters
that were detected in our work after P100 are also in line with a
previous publication which has also shown a biphasic decre-
ment of the CMAP amplitude in ALS mice (Azzouz et al., 1997).
Such latermassive changesare coincidentwith theappearance/
worsening of themajority of functional impairments in the ALS
animals and probably are related to neuronal death in this
phase (Hegedus et al., 2009; Shefner et al., 2002) that is also in
linewith the electromyographical register in the SOD1G93Amice
at the endpoint aboutP120–130 (Azzouzet al., 1997;Miana-Mena
et al., 2005). All in all, it is possible CMAP amplitude has been
decreased in sciatic nerve of SOD1 mice since from the
adolescence to adulthood, in line with very precocious electro-
physiological changes of the latency and nerve conduction
velocity recorded in those mice, and the absence of statistical
significances at P60 and P80 was due to small number of the
employed animals in that analysis.
In fact, the early changes in the tail elevation and
electrophysiological measures before P60 described in our
works may not be accompanied by neuronal death at ventral
horn of the lumbar spinal cord because no changes in the level
of neurofilament 200 and ChAT were detect in the P20 and P60
SOD1G93A mice, which is in agreement to previous papers that
have found first diminution in the counts of motoneurons in
the ALS rodentmodels after P90 (Chiu et al., 1995; Gurney et al.,
1994). That is in line with the knowledge that the deterioration
of the classical symptoms of the disease in the rodentmodel is
accompanied by the death of motoneurons in the spinal cord
(Chiu et al., 1995), which is also in agreement to our work that
showed decreased levels of motoneuron markers (neurofila-
ment 200 and ChAT) in the ventral spinal cord of SOD1G93A
mice at the fully manifested symptomatic phase by P120. It is
possible that the early motor behavioral impairments de-
scribed in this paper are associated to morpho-functional
alterations in still alive motoneurons or in the motoneuron/
Schwann cell unity. It should be highlighted that several
papers have used different histological stainings, including
the recent described Fluoro-Jade C and peroxynitrite, to show
the absence of neuronal death before the onset of classical ALS
symptoms (around P90), despite the early changes in neurons,
i.e., vacuoles in swollen mitochondria, diminution of large
axons in the ventral roots and motor endplate denervation
have been found by P37–P47 of age (Fischer et al., 2004; Chiu
et al., 1995; Yang et al., 2011). Finally, biochemical alterations
in the Schwann cells of sciatic nerve of early ALS have just
been described in animal models (Chen et al., 2010) and the
implicated events in the mechanisms of ALS are the current
subject of ongoing research of our laboratory.
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motor function in ALS mouse model are not sensitive enough
to detect early changes of the disease. Tail elevation score,
footprint analyses and electrophysiological evaluations might
contribute to record disease onset and to provide additional
parameters to study the physiopathology of the disease.4. Experimental procedures
4.1. Animals
Transgenic mice carrying high copy numbers (25±1.5) of the
transgene with the G93A human SOD1 mutation, hereafter
referred to as SOD1G93A were obtained from the Jackson
Laboratory (Bar Harbor, ME, USA) and the colony was
established in the biotery of the São Paulo University Medical
School in a specific pathogen-free environment and main-
tained on a background B6SJL. Male SOD1G93A mice were
crossed with non-transgenic B6SJLF1/J hybrid females as
previously described by Gurney et al., 1994. Mice were
genotyped by PCR amplification of DNA extracted from the
tails to identify the SOD1 mutation (described below). Non-
transgenic littermates were used as controls (wild type, WT).
Animals were kept under controlled temperature and humid-
ity conditionswith a standardized light–dark cycle (lights on at
7.00 a.m. and off at 7.00 p.m.) and free access to food pellets
and tap water. The study was conducted under protocols
approved by the Animal Care and Use Ethic Committee at
University of São Paulo and in accordance with the Guide for
the Care and Use of Laboratory Animals.
The number of mice varied for each test and was about 10–
27 of each group (male and female, and alsoWT and SOD1G93A
mice). We have used five different mice per group in every
time point of the electrophysiological measurements and
Western blot analysis.
For genotyping, the DNA was extracted from all mice tails
by using a protocol described previously (Scorisa et al., 2010).
Briefly, 500 μl of 1 mg/ml K proteinase buffer (Sigma, USA)
(Tris–HCl 20 mM pH 8.0, NaCl 10 mM, EDTA 30 mM pH8.0 and
SDS 0.5%) was added to each tail sample. The suspension was
incubated at 55 to 60 °C during 48 hours and then centrifuged
(16,000×g/10 minutes, at 4 °C). The aqueous phase was
replaced into a new tube and 500 μl cold isopropanol was
added. After gently mixing, DNA became visible and could be
precipitated for centrifugation (16,000×g/2 minutes, at room
temperature). The DNA pellet was washed twice with 500 μl
70% ethanol. After the ethanol removal and a 5-minute drying,
the DNA was resolved in 50 μl TE buffer (10 mM Tris–HCl pH
7.4; 1 mM EDTA in deionized water). DNA samples were stored
at 4 °C until PCR assay. PCR assay was performed as described
earlier (Rosen, 1993), by using the following primers: IMR113
(5′-ATCAGCCCTAATCCATCTGA-3′) and IMR114 (5′-CGCGAC-
TAACAATCAAAGTGA-3′) to amplify SOD1h fragment, and
also IMR042 (5′-CTAGGCCACAGAATTGAAAGATCT-3′) and
IMR043 (5′-GTAGGTGGAAATTCTAGCATCATCC-3′) to amplify
a fragment of murin interleucin-2 as positive control. For each
sample, PCR assay included 12.5 μl PCR Master Mix (2X)
(Fermentas Life Sciences, USA), 0.5 μl of each primer described
above, 1 μg DNA and water free from nucleotides for a finalvolume of 25 μl, submitted to an initial period of 3 minutes at
95 °C, followed by 36 PCR amplification cycles (30 seconds at
95 °C, 30 seconds at 60 °C and 45 seconds at 72 °C) and finally
2 minutes at 72 °C. PCR products with 1 μl blue green could be
visualized in a 1% Agarose gel.
4.2. Assessment of neurological score and body weight
All procedures were performed by two observers blinded to
genotype. Neurological score were performed in mice weekly
starting at postnatal day 20 (P20) by visual inspection.
Neurological score was based on the scale originally described
by Gurney et al. (1994) and modified by others (Weydt et al.,
2003). The scores from “0” to “5” are defined as follow: “0”
indicates a healthy mouse with no classical signs of ALS; “1”
indicates the presence of tremors in the hind legs that occur in
early disease stage; “2” indicates that mice have difficulty in
separating their hind legs when suspended by their tails,
which is indicative of muscle weakness; “3” was given when
mice exhibit difficulty walking, either stumbling or wobbling;
“4” was given when mice were unable to walk on all four legs
and drag their hind legs; “5”was givenwhenmice were unable
to right themselves after 30 seconds.
When the animals reached a score of “4”, the access to food
and water was facilitated by placing food pellets on the cage
floor to all transgenic mice. Reaching a score of “5”, the
animals were euthanized for ethical reasons. Onset was
defined retrospectively as the earliest time when the mice
showed symptoms (score <4) for ≥2 consecutive weeks.
Animals were weighed weekly after P20 with a normal
digital balance. For weighing, animals were placed in a plastic
bowl. Weighing was always performed between 11 a.m. and
2 p.m. to avoid diurnal variations.
4.3. Behavioral analysis
4.3.1. Rotarod, hanging wire and inclined plane
Beginning at P20, we analyzed weekly the motor function
using a rotarod apparatus engineered by Rafael Augusto Reis
Moreira (Brazil). The dimensions and specifications of the
apparatus were described elsewhere (Miana-Mena et al., 2005).
Each animal was given three trials and the maximum period
(seconds) that it could remain on a rotating axle (3.5 cm
diameter; speed of rotation: 15 rpm) without falling was
measured. The test was stopped after an arbitrary limit of
180 seconds. In the first 2 weeks, an adaptation period of three
trials was performed before the beginning of the recordings.
Hanging wire test began at P20 and was performed weekly,
24 hours before the rotarod test. Animals were placed on the
wire lid of a conventional housing cage. The lid was gently
turned upside down, 50 cm above a soft surface to avoid
injuries. The latency to fall was timed. Each mouse was given
up to three attempts for a maximum of 180 seconds and the
longest period was recorded.
The inclined plane apparatus consisted of a hingedwooden
board which was set at an angle of 0º (Guzen et al., 2009).
The animals at P20 were placed head up on the board and it
was raised at constant speed until the mouse slip out the
board. The maximum angle reached without slip out was
recorded.
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Tail elevation was determined weekly starting at P20 by visual
inspection using the tail score during the assessment of
neurological score. Tail score was based on the SHIRPA tail
scale, procedure developed by Rogers et al. in MRC, United
Kingdom (Niimi and Takahashi, 2009; Rogers et al., 1997) and
modified by our group. The scores “0” to “3” were defined as
follows: “0” indicates vertical position of the tail (maximum
elevation); “1” indicates horizontally extended tail; “2” indi-
cates dragging tail for more than 20 seconds; “3” was given
when the tail displayed proximal contracture and distal laxity
(mice with this score were in the terminal phase of the
disease).
4.3.3. Footprint analyses
The footprint test was used to compare the gait of SOD1G93A
transgenic mice to WT control mice. To obtain footprints, the
hind feet of the mice were coated bilaterally with a black
nontoxic paint. The animalswere then allowed towalk along a
50-cm-long, 10-cm-wide runway (with 10-cm-high walls). All
mice had two training runs and were then given one run per
week, beginning at P20. A fresh sheet of paper was placed on
the floor of the runway for each run. The footprint patterns
were analyzed for three classical step parameters (all mea-
sured in centimeters) (Fig. 6A). (1) Stride length was measured
as the average distance of forward movement between each
stride. (2) Hind–base width was measured as the average
distance between left and right hind footprints. This valuewas
determined by measuring the perpendicular distance of a
given step to a line connecting its opposite preceding and
proceeding steps. (3) Spreading of toes was measured as the
average of the distance between the first and fifth toes.
For each step parameter, two values were measured from
each run, excluding footprints made at the beginning and end
of the run where the animal was initiating and finishing
movement, respectively. The mean value of each set of two
values was used in subsequent analyses. When the gait
pattern became “dragged” and irregular, a “0” centimeter
was assigned for each animal. Footprints located directly side
by side indicate sitting of the animal and were not included in
the evaluation of steep length (Dijkstra et al., 2000).
4.4. Automatic evaluation
The motor behavior was evaluated in an open-field by
automatic recording of motor activity based on movement
time, without any intervention by the investigator, using an
infrared motion sensor monitor (Coulbourn Instruments, USA)
asdescribedpreviously (Andradeet al., 2010; GomideandChadi,
2004). The experimental room was diffusely illuminated and
kept at constant temperature and humidity (Chadi et al., 1993).
Rats were individually placed in polyetilene cages
(37×17×30 cm), which had an infrared motion sensor on the
top of thewall, and the registerwas done in blocks of 2-minutes
observation timeduring30minutes (Chadietal., 2001). Fromthe
resulting data, the following dependent measures parameters
were calculated: without-movement time, which is defined as
themean of the time (seconds) duringwhich the animal did not
move or moved for a time less than 0.01 second during the
observation time; without-movement events are the meannumber of events registered at every without-movement time
during the observation time; small-movement time, which is
defined as the mean of the time (seconds), during which the
animal moved between a time interval superior to 0.01 second
but inferior to 0.1 second, during the observation time; small-
movement events are themean number of events registered at
every small-movement time, during the observation time;
large-movement time, which is defined as the mean of the
time (seconds) during which the animal moved in a time
interval superior to 1.0 second; large-movement events are the
mean number of events registered at every large-movement
time, during the observation time. The data were transferred to
a host computer and analyzed by specific software. Only the
numbers of without-movement, small-movement and large-
movement events were used in the present evaluation. The
graphicswereplotted inperiods in x-axis, corresponding to: first
period (P40–60), second period (P70–80), third period (P90–100)
and fourth period or end stage of disease (P110–120). It has to be
emphasized that themovements (largeor small) are interrupted
by periods of time-without movement, except when animal
develop continuous such larger movements much bigger in
time that 1.0 second (an extremely anomalous situation that
has not occurred in the present work) that would decrease the
time without movement events.
4.5. Electrophysiological measurements
The electrophysiological measurements were recorded in
different groups of male SOD1G93A mice and wild-type animals
at P20, P40, P60, P80, P100 and P120 anesthetized with ketamine
chlorhydrate (Ketalar) and diazepam (Valium) (1 ml/kg of a
solution containing11.25mgketalar and0.375 mgofvalium; IP).
Mice were deeply anesthetized and normal body temperature
was maintained using a heater. The sciatic nerve was exposed
and the animals were submitted to electrophysiological evalu-
ation consisting of measurement of compound motor action
potential (CMAP). Such evaluation aimed at checking nerve
electrophysiological integrity and measuring parameters used
in calculating the mean between the amplitudes, the mean
between the latencies and the mean between the conduction
velocities of each potential. To reduce possible interference, 2
ground electrodes were installed after surgical nerve exposure,
one of which was a monopolar straight needle electrode (26 G)
placed within the muscle adjacent to the nerve; the other
ground electrode was manufactured from 316 L stainless steel
wire and its extremity was of helical configuration so as to
surround the nerve and increase the contact area. The bipolar
electrodes for CMAP stimulationweremanufactured from 316 L
stainless steel wire 0.5 mm in diameter, with anode–cathode
separation of 1 mm. Recordings were made on a 2-channel
electromyography system (Keypoint portable; Medtronic, Skov-
lunde, Denmark), with thehigh-frequency filter set at 5 kHz and
the low-frequency filter set at 2 Hz. Electric stimulation
produces artifacts; to reduce them, rectangular monophase
electric pulses with a pulse width of 0.04 ms were used.
For CMAP measurements the stimulation electrode was
placed on the nerve at distance of 1 cm from the recording
electrode placed on the gastrocnemius muscle through
percutaneous puncture in the distal third of the paw,
ipsilaterally to the surgical procedure, with a coaxial needle.
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ed recording at the motor point. The CMAP amplitude was
measured only in positive peak (Dumitru and DeLisa, 1991).
The latency of evoked potentials was measured in millise-
conds as described elsewhere (Azzouz et al., 1997). From such
recorded potential, the conduction velocity was calculated
using the distance of 1 cm divided by latency. The records of
SOD1G93A animals were compared with WT animals at the
studied time points.
4.6. Western blot analysis
WT and SOD1G93A female animals at P20 (n=5), P60 (n=5) and
P120 (n=5) were killed by decapitation. The lumbar spinal
cords of rodents were rapidly removed, trimmed in ventral
and posterior parts and immediately frozen in dry ice and
stored in −70 °C freezer until processing.
Tissues from the ventral part of mouse spinal cords,
including the ventral horn, were homogenized in lyses buffer
containing 1% protease inhibitor cocktail (Sigma), 1% NP40
(Sigma), 0.5% sodium deoxycholate (Sigma), 1 mM EDTA
(Sigma), 1 mM EGTA (Sigma), diluted in phosphate-buffered
and centrifuged (14,000 rpm) for 30 minutes at 4 °C as de-
scribed previously (Chadi et al., 2008; Silva et al., 2009);
supernatants were transferred into new tubes and stored at
−70 °C until use.
Protein concentration was determined according to the
method of Bradford (1976). 60 μg of protein was separated on a
10% sodium dodecyl sulfate (SDS)-polyacrylamide (Bio-Rad,
USA) by an electrophoresis gel. Proteins were transferred onto
PVDF membranes (Bio-Rad) for 1 hour in 100 V. After 30-
minute blocking with 10% milk in Tris-buffered saline-tween
(TBS-T), the membranes were incubated over night at 4 °C
with a rabbit antibody to neurofilament 200 (NF 200) (1:10,000
in 3% milk/TBS-T, Sigma) or a goat antibody to choline
acetyltransferase (ChAT) (1:1000 in 3% milk/TBS-T, Millipore,
USA). Membranes were washed twice for 10 minutes in TBS-T
and incubated at room temperature for 1 hour with IgG-ECL
anti-rabbit or anti-goat conjugated secondary antiserum
(1:2000–10,000, respectively; Amersham Biosciences, UK).
Blots were washed for 10 minutes twice with TBS-T and once
with TBS. After final washes, the membranes were incubated
with Immobilon Western Chemiluminescent HRP Substrate
(Millipore, USA) for 3 minutes. The membranes were exposed
to an X-ray film for imaging (Hyperfilm™ ECL, Amersham
Biosciences, USA) to visualize protein bands. After, blots were
stripped, blocked and incubated with rabbit antibody to
β-tubulin III (1:30,000 in 3% milk/TBS-T, Sigma) during 1 hour
at room temperature and developed as previously described.
The films were scanned (HP Scanjet G4000 series) and NF 200
and ChAT protein levels were quantified by densitometry by
means of a computer-assisted image analyzer using Image J
software (version 1.43u, National Institute of Health, USA).
Density normalization was done by dividing the proteins by
β-tubulin III density values.
4.7. Statistical analysis
Survival and tremor onset were analyzed by Kaplan–Meier
(log-rank test). Statistical analyses for all behavioral dataconsisted of two-way repeated measures analyses of variance
(RM ANOVA) to compare genotypes (SOD1G93A and WT) and
gender (males and females) as the between factors, variable
and time (age), as the within factors variable. Differences
between groups were identified via post hoc comparisons.
Statistical significance for electrophysiological measurements
between the males SOD1G93A and WT was assessed using
Mann–Whitney U-test.
In caseswhere amousehad tobe killed before the endof the
study (reaching a score of “5”) and in rare cases where data
points were missing (from low motivation to perform the
motor tasks), those points were filled in with the mean of that
time point (Smittkamp et al., 2008). All analyses were
performed using Prism 5.0 (Graph Pad, CA). Data were
presented as mean±SEM and significance level was set at
p<0.05.
In the Western blot analysis experiments, the one-way
analysis of variance (ANOVA) was applied to compare the
transgenic and wild-type animals, using Tukey's multiple
comparison post test to identify statistical significances
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